Načítá se...
Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus
BACKGROUND: Patients in refractory status epilepticus (RSE) may require treatment with continuous intravenous anesthetic drugs (cIVADs) for seizure control. The use of cIVADs, however, was recently associated with poor outcome in status epilepticus (SE), raising the question of whether cIVAD therapy...
Uloženo v:
| Vydáno v: | Crit Care |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6249897/ https://ncbi.nlm.nih.gov/pubmed/30463604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-018-2235-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|